Keywords: 2nd-qtr, rx, dtc, spending, rises, direct-to-consumer, advertising
US 2nd-Qtr Rx DTC Spending Rises 25%
Article | 06 November 1998
US spending on direct-to-consumer advertising of prescription drugs insecond-quarter 1998 grew 25% over the like, year-earlier period, says Scott-Levin's DTC Advertising Audit. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
